The DOI matches its Crossref record.
Pharmacokinetic studies on minocycline in man
Abstract
Minocycline, a new member of the tetracycline series, has been reported to have a high level of activity against tetracycline‐sensitive organisms and significant activity against tetracycline‐resistant staphylococci. Results presented show that in man it has a biologic half‐life apprOXimately that of doxycycline but appreciably longer than that of other tetracyclines. It appears to be more rapidly absorbed than doxycycline, demethylchlortetracycline, and methacycline. Evidence indicates that with minocycline, like doxycycline, but unlike other tetracycline antibiotics, absorption following oral administration is essentially complete. Lower values for renal clearance are found for minocycline than for the other tetracyclines studied. Of the minocycline recovered, a higher percentage was excreted in the feces and biologic transformation was greater than with the other tetracyclines. Minocycline has greater lipophilic properties than other tetracyclines, which may account for the highly favorable ratios of tissue to serum concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
The Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
Casha, S., Zygun, D., McGowan, M. D., Bains, I., Yong, V. W., & John Hurlbert, R. (2012) · Brain · doi:10.1093/brain/aws072 · Cited by 408
Clinical Pharmacokinetics of Doxycycline and Minocycline
Saivin, S., & Houin, G. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815060-00001 · Cited by 350
Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects
Muralidharan, G., Micalizzi, M., Speth, J., Raible, D., & Troy, S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.220-229.2005 · Cited by 333
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome: Table 2
Gough, A., Chapman, S., Wagstaff, K., Emery, P., & Elias, E. (1996) · BMJ · doi:10.1136/bmj.312.7024.169 · Cited by 311
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146
Zabad, R. K., Metz, L. M., Todoruk, T. R., Zhang, Y., Mitchell, J. R., Yeung, M., Patry, D. G., Bell, R. B., & Yong, V. W. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070319 · Cited by 120
Khodaie-Ardakani, M.-R., Mirshafiee, O., Farokhnia, M., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Rezaei, F., Salehi, B., Yekehtaz, H., Ashrafi, M., et al. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.051 · Cited by 104
Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
Buller, K. M., Carty, M. L., Reinebrant, H. E., & Wixey, J. A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21890 · Cited by 73
Minocycline mitigates the effect of neonatal hypoxic insult on human brain organoids
Boisvert, E. M., Means, R. E., Michaud, M., Madri, J. A., & Katz, S. G. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1553-x · Cited by 45
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36
Chemical Modification of the Tetracyclines
Rogalski, W. (1985) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-70304-1_5 · Cited by 28
Metadata
- Authors
- Macdonald, H., Kelly, R. G., Allen, E. S., Noble, J. F., & Kanegis, L. A.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1973-09
- Volume
- 14
- Issue
- 5
- Pages
- 852-861
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W21578373
- Cited by
- 222
- References
- 0
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.